A polypeptide of Mr 26,000 and pI 6.7 that was markedly increased in rat livers bearing hyperplastic nodules (HNs) induced by chemical carcinogens was identified immunochemically as the subunit of neutral glutathione (GSH) transferase (GSHTase; RX:glutathione R-transferase, EC 2.5.1.18; also called GSH S-transferase) purified from placenta (GSHTase-P) and was demonstrated immunohistochemically to be localized in preneoplastic foci and HNs. In the present study, GSHTase-P has been purified from the HN-bearing liver, and the distribution and inducibility have been examined quantitatively using anti-GSHTase-P antibody. Elevation of GSHTase-P in the HN-bearing livers was also confirmed by in vitro translation of mRNAs isolated from the HN-bearing livers. The purified GSHTase-P was homogeneous in size but had two charge isomers on two-dimensional gel electrophoresis. In normal tissues, including liver, placenta, and fetal liver, the protein content of GSHTase-P was generally low but was significantly high in kidney and pancreas. In contrast, the amount of GSHTase-P in HN-bearing livers (primary hepatomas) and transplantable Morris hepatoma 5123D were several 10-fold higher than that in normal liver but were undetectably low in transplantable Yoshida ascites hepatoma AH 130. Different from ordinary drug-metabolizing enzymes, GSHTase-P was uninducible by administration of drugs and carcinogens prior to appearance of the preneoplastic foci and HNs. In addition, species specificity of GSHTase-P was low as it was crossreactive among rat, hamster, and human.
Much attention has been focused on the morphological, histochemical, and biochemical properties of the preneoplastic cells such as enzyme-altered foci and hyperplastic nodules (HNs) induced at early stages of chemical hepatocarcinogenesis (1) (2) (3) (4) (5) . Among (pre)neoplastic markers so far found, epoxide hydrase (6) , an isozyme of UDPglucuronosyltransferase, and a molecular form ofglutathione (GSH) transferase (GSHTase; RX:glutathione R-transferase, EC 2.5.1.18; also called GSH S-transferase) were remarkable since their activities increased with the appearance of foci and HNs but decreased with the dedifferentiation ofhepatomas (7) . Nevertheless, most of the enzymatic activities were significantly high in normal hepatocytes and were easily inducible by drugs and carcinogens. Thus, specific preneoplastic markers are required for the analysis of the multistep development of cancer cells.
Several investigators (8) (9) (10) 34) have detected proteins that are increased in the preneoplastic cells induced in livers of rats administered diethylnitrosamine and N-2-fluorenylacetamide according to Solt and Farber (4) . Eriksson et al. (10) observed increased polypeptides of Mrs 27,000 and 21,000 in isolated HNs induced by six models for the chemical hepa-
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 3964 tocarcinogenesis. In our studies of isozymic alterations during chemical hepatocarcinogenesis, especially of drugmetabolizing enzymes (7, (11) (12) (13) (14) (15) , we observed by twodimensional gel electrophoretic analysis of the cytosolic proteins of the HN-bearing rat livers that a polypeptide of Mr 26,000 and pI 6.7 [designated polypeptide (26/6.7)] increased most markedly together with three other proteins. This polypeptide was identified immunochemically as the subunit of a neutral GSHTase that was purified from rat placenta. This placental form (GSHTase-P) was demonstrated to be localized in HNs and in foci positive for y-glutamyltransferase (GluTase; y-glutamyl transpeptidase, EC 2.3.2.2) (14) .
In the present study, GSHTase-P has been purified from HN-bearing rat livers, some chemical properties have been characterized, and the content of this protein in normal, preneoplastic, and neoplastic tissues and its inducibility in rat livers by drugs and carcinogens have been examined.
MATERIALS AND METHODS Animals. Male Sprague-Dawley rats, weighing 150-160 g, were obtained from Charles River-Oriental Yeast (Tokyo).
Chemicals. Chemicals were obtained as follows; diethylnitrosamine, 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB), and 3-methylcholanthrene, Tokyo Chemicals; N-nitroso-bis(2-hydroxypropyl)amine, Nakarai Chemicals (Tokyo); butylated hydroxyanisol, Wako Chemicals (Tokyo); phenobarbital, Sankyo, Tokyo; PCB, Kanegafuchi Chemical (Osaka).
Induction of Preneoplastic Enzyme-Altered Foci, HNs, and Hepatomas. Preneoplastic foci, HNs, and hepatomas were induced in rat livers by administration of diethylnitrosamine (200 mg/kg of body weight) and N-2-fluorenylacetamide (0.02% in diet) plus partial hepatectomy according to the protocol of Solt and Farber (4) . Foci and HNs were induced 4 to 6 wk after diethylnitrosamine injection, and large and dense HNs were detectable with the naked eye after 6 to 8 wk. Hepatomas were induced by diethylnitrosamine followed by N-2-fluorenylacetamide without hepatectomy or by 3'-Me-DAB (0.06% in diet) alone as described (11, 15 Antibody Preparation. Antibody to GSHTase-P purified from HN-bearing rat livers was prepared in a rabbit as reported (18) .
Single Radial Immunodiffusion Method. Single radial immunodiffusion was performed with the antibody to GSHTase-P as described by Mancini et al. (19) .
Two-Dimensional Gel Electrophoresis. Two-dimensional gel electrophoresis (isoelectric focusing/sodium dodecyl sulfate electrophoresis) was performed as described by O'Farrell (21) and modified by Hirsch et al. (22) .
Amino Acid Analysis. Purified GSHTase-P (300 ,ug) and an amino acid standard mixture were hydrolyzed in 6 M HCl at 110°C for 20 hr, and the amino acid composition was analyzed with an amino acid analyzer, model JLC-6AH, JEOL.
In Vitro Translation of mRNAs. mRNAs were isolated from normal and HN-bearing rat livers, and in vitro translation in a rabbit reticulocyte lysate translation system was performed as reported (23) .
RESULTS
Purification of GSHTase-P from HN-Bearing Rat Livers. HN-bearing rat livers (19.7 g) were homogenized in 5 vol of 0.25 M sucrose and centrifuged at 10,000 x g for 10 min and further centrifuged at 105,000 x g for 45 min. The supernatant was dialyzed against 10 mM KH2PO4 (pH 6.7) overnight and then applied to a column of CM-Sephadex (3.5 x 8 cm) that had been equilibrated with the phosphate buffer. Flowthrough fractions were applied to a column of S-hexyl-GSHSepharose 6B (1.2 x 8 cm) (24) and washed with =200 ml of 10 mM Tris, pH 7.8/0.2 M NaCl, and the adsorbed GSHTases were eluted with the Tris buffer containing 5 mM S-hexyl-GSH. Active fractions were dialyzed against 10 mM Tris (pH 8.1) overnight and applied to a column of DE-52 cellulose (1.5 x 20 cm), followed by elution with a NaCl linear gradient from 0 (200 ml) to 100 mM (200 ml). Three major peaks (I, II, and III) were observed in the elution profile, in (20) . (Inset) Two-dimensional gel electrophoretic pattern of GSHTase-P (12 ,g) eluted in the second peak fraction.
which GSHTase-P was detectable in the second peak fraction (Fig. 1) . The two-dimensional gel electrophoretic pattern of GSHTase-P is shown in Fig. 1 Amino Acid Composition of GSHTase-P. The amino acid composition of GSHTase-P purified from the HN-bearing rat livers is shown in Table 2 together with that of GSHTase-tr from human placenta as reported by Guthenberg and Mannervik (25) . The two enzyme subunits were very similar in amino acid composition. Both GSHTase-P and GSHTase-ir contained less lysine and arginine than did the basic GSHTases such as L2 and A2 (26) .
Ouchterlony Double-Immunodiffusion of GSHTase-P. When the antibody to GSHTase-P was placed in the center well, single strong precipitin lines were formed with the cytosol from HN-bearing rat liver and with the purified GSHTase-P, but very faint ones were formed with those from normal liver and placenta ( Fig. 2A) . No precipitin bands were formed with purified preparations of basic GSHTases, BL or AC (27) . GSHTase-P was crossreactive with the acidic GSHTase-ir from human placenta and GSHTase-p from human erythrocyte (Fig. 2) . It also was observed that a weak precipitin line was formed with the cytosol from normal hamster liver and a strong one was formed with that from HN-bearing liver of a hamster administered N-nitroso-bis(2- GSHTase was assayed with CIN2B as substrate, and the protein content of GSHTase-P was quantitated by single radial immunodiff-usion. hydroxypropyl)amine. These results indicate that the placental GSHTase is crossreactive among rat, hamster, and human.
Protein Content of GSHTase-P in Normal, Preneoplastic, and Neoplastic Tissues. The protein contents of GSHTase-P in normal tissues, HN-bearing livers, and hepatomas were determined by single radial immunodiffusion. The protein content of GSHTase-P was generally very low in adult and fetal livers, placenta, heart, and other tissues Ag/g of tissue) but significantly higher in kidney and pancreas (Table  3 ). Significant but weak induction of GSHTase-P (-2-fold) was observed by 70% partial hepatectomy. The protein contents in HN-bearing livers and hepatomas induced by diethylnitrosamine and N-2-fluorenylacetamide plus partial hepatectomy were 20-to 50-fold and 10-to 30-fold higher than that in the normal liver, which corresponded to 0.97 ± 0.43% and 0.49 + 0.20% (mean + SD) of the soluble cytosolic proteins, respectively. The protein contents in hepatomas induced by 3'-Me-DAB and Morris hepatoma 5123D were as high as those in the above HN-bearing livers induced by diethylnitrosamine and N-2-fluorenylacetarnide. However, GSHTase-P was undetectably low in AH 130, indicating that it seems to decrease with increased dedifferentiation of hepatomas. GSHTase-P was also undetectable in primary 3-methylcholanthrene-induced fibrosarcoma. Induction of GSHTase-P by Short-Term Administration of Drugs or Carcinogens. Degrees of induction of GSHTase-P were low in livers of rats administered phenobarbital, PCB, N-2-fluorenylacetamide, 3'-Me-DAB, and 3-methylcholanthrene; however, administration of butylated hydroxyanisole induced about twice the amount of GSHTase-P as in control liver. In Vitro Translation of mRNAs Isolated from Normal and HN-Bearing Livers. Two-dimensional gel electrophoretic patterns of the glutathione-affinity column-bound GSHTases translated from mRNAs of normal and HN-bearing livers are shown in Fig. 3A and B, respectively. The amounts of all five subunits (Ya, Yb, Yb', Yc, and Yp) synthesized from mRNAs of preneoplastic liver were much higher than those of normal liver. Among subunits that are present in normal liver, the increased amount of Yb was prominent, as noted in vivo (15) . However, the Yp subunit was increased most markedly as it was practically undetectable in the normal liver pattern. Microheterogeneous subunits (charge isomers) were detectable not only for the Yp subunit as Ypl and Yp2 but also for Yb and Yb' subunits as Yb1 and Yb2, and Yb'l and Yb'2, respectively. The molecular weight and pI values of these heterogeneous and microheterogeneous subunits were identical with those observed in the liver cytosol. Microheterogeneity of the GSHTase subunits will be reported elsewhere.
DISCUSSION
We have demonstrated immunohistochemically (14) that GSHTase-P is localized in HNs; in this study, GSHTase-P was purified from whole rat livers bearing HNs induced by administration of diethylnitrosamine and N-2-fluorenylacetamide. Basic GSHTases were removed selectively by adsorption to a column of CM-Sephadex, and unbound neutral and acidic GSHTases were subjected to GSH-Sepharose 6B affinity chromatography. GSHTase-P was finally separated from the acidic and residual basic forms on DE-52 cellulose chromatography. The purified enzyme was homogeneous in size, but two charge isomers were detectable on twodimensional gel electrophoresis. They were named Ypl (26/6.7) and Yp2 (26/6.3) but were indistinguishable immunochemically.
GSHTase-P was different from basic GSHTases in immunochemical properties (15) and amino acid composition (26) . GSHTase-P was crossreactive among rat, hamster, and human, showing that the antibody to GSHTase-P is useful for immunohistochemical staining of hamster hepatic and pancreatic preneoplastic foci and HNs (35) .
GSHTase-P could most conveniently be quantitated by single radial immunodiffusion as described by Mancini et al. (19) . The protein content of GSHTase-P was generally low in normal tissues, including adult and fetal livers, regenerating livers, and others, except that it was significantly high in kidney and pancreas. GSHTase-P was also low in placenta, although it was isolated originally from that tissue where it is the predominant molecular form of GSHTase. In contrast, GSHTase-P level was high in preneoplastic and neoplastic tissues. GSHTase-P contents in the HN-bearing livers and hepatomasinducedbydiethylnitrosamine/N-2-fluorenylacetamide and in hepatomas induced by 3'-Me-DAB were 30-to 50-fold higher than that in the normal liver. It is noteworthy that GSHTase-P was also high in the transplantable moderately differentiated Morris hepatoma 5123D but was undetectably low in the poorly differentiated Yoshida ascites hepatoma AH 130.
Consistent with the immunohistochemical observation that GSHTase-P was localized in the GluTase-positive foci and HNs (14) , degrees of elevation of GSHTase-P and GluTase in the preneoplastic livers were similar (30-to 50-fold), but GluTase activity was relatively high in the hepatomas (28), whereas GSHTase-P level was rather low. Thus, it seems that GSHTase-P is more characteristic of preneoplastic than neoplastic cells. As noted above, it appears that GSHTase-P is not an organ-or tissue-specific enzyme when compared with GluTase, whose activity is extremely high in kidney. The high GluTase activities of preneoplastic and neoplastic tissues are much lower than that of normal kidney (28) .
GSHTase-P was practically uninducible in rat livers by short-term administration of drugs and carcinogens such as phenobarbital, PCB, N-2-fluorenylacetamide, 3'-Me-DAB, and 3-methylcholanthrene; however, butylated hydroxyanisole induced GSHTase-P slightly in periportal areas as detected immunohistochemically.
Since GSHTase-P does not increase prior to the appearance of preneoplastic foci and HNs and since it is high in the transplantable Morris hepatoma 5123D as well, GSHTase-P increase is not due simply to administration of drugs or carcinogens.
Recently, it was confirmed that the Mr 21,000 protein found by Farber and co-workers (9, 10) was identical with GSHTase-P when examined with the antibody to GSHTase-P prepared by us (E. Farber, personal communication). Although the molecular weight of the subunit of GSHTase-P was estimated to be 26,000 by us with carbonic anhydrase (Mr 30,000) as the critical standard, it could be estimated to be 21,000 as well with a-chymotrypsinogen (Mr 25,000) as the standard. Recently, Reddy et al. estimated the molecular weight of GSHTase subunits Ya, Yb, and Yc to be 25,600, 27,000, and 28,000, respectively, from cDNA analysis (29) . Based on these values, the molecular weight of the subunit of GSHTase-P can be calculated to be 25,100.
As observed by Farber et al., it is interesting to note that the Mr 21,000 protein-i.e., GSHTase-P-is increased in the preneoplastic cells independent of their mode of induction (9, 10) . It should also be noted that GSHTase-P is abundant in the preneoplastic cells because the actual protein content in the soluble cytosolic proteins must be several-fold higher than the apparent one (l1%) in the HN-bearing livers by taking into account its localization at the foci and HNs. When the protein content of GluTase was estimated from the enzymatic activities, with its specific activity assumed to be 1030 units/mg of protein (28), GSHTase-P was 200-to 400-fold higher than GluTase in protein content in the preneoplastic livers.
Neutral and acidic GSHTases have been observed by Biochemistry: Satoh et al.
Proc. Natl. Acad. Sci. USA 82 (1985) several investigators (30) (31) (32) . It is possible that GSHTase-P is identical with the tissue-specific GSHTase of Mr 24,000, which was found by Tu and co-workers (29, 30) . The function of GSHTase-P increase in HNs and hepatomas is unknown. However, it has been pointed out that preneoplastic cell populations are resistant to the cytotoxic action ofcarcinogens (1, 33) . Since the GSHTases are a group of multifunctional enzymes involved in the detoxification of various drugs and carcinogens, GSHTase-P, which is abundant in the preneoplastic cells, may be expected to have a crucial role in relation to the resistance mechanism or more directly to the growth of these cells.
